Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Equity Ratio (2020 - 2024)

RAPT Therapeutics' Equity Ratio history spans 5 years, with the latest figure at 0.88 for Q3 2024.

  • For Q3 2024, Equity Ratio rose 1.77% year-over-year to 0.88; the TTM value through Sep 2024 reached 0.88, up 1.77%, while the annual FY2023 figure was 0.85, 7.89% down from the prior year.
  • Equity Ratio for Q3 2024 was 0.88 at RAPT Therapeutics, up from 0.86 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.94 in Q2 2021 and bottomed at 0.84 in Q1 2024.
  • The 5-year median for Equity Ratio is 0.88 (2024), against an average of 0.89.
  • The largest annual shift saw Equity Ratio rose 8.79% in 2021 before it fell 7.89% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 0.88 in 2020, then increased by 7.15% to 0.94 in 2021, then decreased by 1.85% to 0.92 in 2022, then dropped by 7.89% to 0.85 in 2023, then grew by 3.8% to 0.88 in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Equity Ratio are 0.88 (Q3 2024), 0.86 (Q2 2024), and 0.84 (Q1 2024).